Investment Rating - The investment rating for the beauty care industry is "Recommended" (maintained) [2][22]. Core Insights - The beauty care industry is experiencing significant growth driven by technological innovation and personalized services, with AI and big data being utilized to provide tailored solutions for consumers [4][22]. - The report emphasizes the importance of new material technologies and the rise of personalized services as mainstream trends in the medical beauty sector [22]. Summary by Sections Recent Market Performance - From March 3 to March 7, 2025, the Shenwan Beauty Care Index increased by 2.94%, with notable stock performances from companies like Kedi-B and Juzhi Biotechnology [7][8]. Industry News - The report highlights the successful launch of the "China Quality Flagship Store" by Hangzhou Meilai, which aims to redefine high-quality medical beauty standards through a comprehensive service system [12]. - Juzhi Biotechnology's patented recombinant human type IV collagen has been approved, marking a breakthrough in the medical beauty industry [4]. Key Company Announcements - Huadong Medicine's optical radiofrequency therapy device V30 has received acceptance from the National Medical Products Administration (NMPA), showcasing its multifunctional capabilities [10]. - Betaini's brand "Beforteen" has integrated AI technology for acne diagnosis, enhancing its product offerings [11]. Investment Recommendations - The report suggests focusing on companies with strong growth potential, including: 1. Marubi Biotechnology, known for its comprehensive brand matrix and product range [22]. 2. Juzhi Biotechnology, which is expected to grow rapidly due to the rise of recombinant collagen and domestic beauty trends [22]. 3. Betaini, which combines high cost-performance with strong product innovation [22]. 4. Aimeike and Longzi Co., which are expected to drive growth through flagship products and extensive product pipelines [22]. 5. Huadong Medicine, which shows strong potential in innovative drug development and medical beauty product pipelines [22].